MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spitzmaul, G.
Right arrow Articles by Bouzat, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spitzmaul, G.
Right arrow Articles by Bouzat, C.

Vol. 60, Issue 2, 235-243, August 2001

The Noncompetitive Inhibitor Quinacrine Modifies the Desensitization Kinetics of Muscle Acetylcholine Receptors

Guillermo Spitzmaul, James P. Dilger, and Cecilia Bouzat

Instituto de Investigaciones Bioquímicas, Universidad Nacional del Sur-Consejo Nacional de Investigaciones Científicas y Técnicas, Bahía Blanca, Argentina (G.S.,C.B.); and Department of Anesthesiology, State University of New York Stony Brook, Stony Brook, New York (J.P.D.)

Quinacrine has been shown to act as a noncompetitive inhibitor of the nicotinic acetylcholine receptor (nAChR). However, its mechanism of action is still a matter of controversy. We analyzed in detail the action of quinacrine at both the single-channel and macroscopic current levels. The main effect of quinacrine is a profound concentration-dependent decrease in both the frequency of opening events and the duration of clusters elicited by high acetylcholine concentrations. Quinacrine also significantly increases (40-fold at 30 µM) the decay rate of macroscopic currents elicited by rapid perfusion of acetylcholine to outside-out patches. This decay is still well-described by a single exponential. Quinacrine has very little effect on the peak amplitude of the response, suggesting that it acts mainly on open channels. The recovery from desensitization after removal of acetylcholine is delayed in the presence of quinacrine. Results from both single-channel and macroscopic current recordings indicate that quinacrine increases the rate of nAChR desensitization and stabilizes the desensitized state. Interestingly, in equilibrium agonist-binding assays, quinacrine does not promote the typical high-affinity desensitized state. Thus, quinacrine seems to induce an intermediate state exhibiting the permeability but not the agonist binding properties of desensitization.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. Bartos, K. L. Price, S. C. R. Lummis, and C. Bouzat
Glutamine 57 at the Complementary Binding Site Face Is a Key Determinant of Morantel Selectivity for {alpha}7 Nicotinic Receptors
J. Biol. Chem., August 7, 2009; 284(32): 21478 - 21487.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. Bouzat, M. Bartos, J. Corradi, and S. M. Sine
The Interface between Extracellular and Transmembrane Domains of Homomeric Cys-Loop Receptors Governs Open-Channel Lifetime and Rate of Desensitization
J. Neurosci., July 30, 2008; 28(31): 7808 - 7819.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
P.-W. Phuan, J. A. Zorn, J. Safar, K. Giles, S. B. Prusiner, F. E. Cohen, and B. C. H. May
Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds
J. Gen. Virol., April 1, 2007; 88(4): 1392 - 1401.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Bartos, D. Rayes, and C. Bouzat
Molecular Determinants of Pyrantel Selectivity in Nicotinic Receptors
Mol. Pharmacol., October 1, 2006; 70(4): 1307 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Rayes, G. Spitzmaul, S. M. Sine, and C. Bouzat
Single-Channel Kinetic Analysis of Chimeric {alpha}7-5HT3A Receptors
Mol. Pharmacol., November 1, 2005; 68(5): 1475 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Rayes, M. J. De Rosa, M. Bartos, and C. Bouzat
Molecular Basis of the Differential Sensitivity of Nematode and Mammalian Muscle to the Anthelmintic Agent Levamisole
J. Biol. Chem., August 27, 2004; 279(35): 36372 - 36381.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. Bahadi, P. V. Farrelly, B. L. Kenna, C. C. Curtain, C. L. Masters, R. Cappai, K. J. Barnham, and J. I. Kourie
Cu2+-induced modification of the kinetics of A{beta}(1-42) channels
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C873 - C880.
[Abstract] [Full Text] [PDF]

Home page
 JGPHome page
R. J. Prince, R. A. Pennington, and S. M. Sine
Mechanism of Tacrine Block at Adult Human Muscle Nicotinic Acetylcholine Receptors
J. Gen. Physiol., August 26, 2002; 120(3): 369 - 393.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics